The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Table 2

The detection rate of H. pylori, HSV-1, CMV in the gastric mucosa of patients with SLE and APS.

Infectious agents	The detection rate of infectious agents in the groups
	PAPS, n = 20	SLE+APS, n = 26	SLE, n-39	All patients, n=85
H. pylori, n (%)	14 (70.0)	21 (80.8)	31 (79.5)	66 (77.6)#
CagA, n (%)	9 (45.0)	13 (50.0)	25 (64.1)	47 (55.3)
HSV-1, n (%)	11 (55.0)	10 (38.5)	12 (30.8)	33 (38.8)
CMV, n (%)	6 (30.0)	6 (23.1)	10 (25.6)	22 (25.9)#
No infections, n (%)	4 (20.0)	3 (11.5)	3 (7.7)	10 (11.8)

Note:
- χ² = 26.18; P = 0.00003; OR = 5.47; at 95% CI, RR = 2.0<1.50<RR<2.67; comparison of the detection rate for H. pylori and HSV-1.
#- χ² = 45.34; P < 0.0001; OR = 9.95; at 95% CI, RR = 3.00<2.06<RR<4.38; comparison of the detection rate for H. pylori and CMV.